Cargando…

Discovery of novel non-peptidic and non-covalent small-molecule 3CL(pro) inhibitors as potential candidate for COVID-19 treatment

Detalles Bibliográficos
Autores principales:	Jiang, Zhidong, Feng, Bo, Zhang, Yumin, Nie, Tianqing, Liu, Hong, Li, Jia, Su, Haixia, Zhang, Leike, Zang, Yi, Zhou, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201506/ https://www.ncbi.nlm.nih.gov/pubmed/37217487 http://dx.doi.org/10.1038/s41392-023-01482-9

Ejemplares similares

Correction: Discovery of novel non-peptidic and non-covalent small-molecule 3CL(pro) inhibitors as potential candidate for COVID-19 treatment
por: Jiang, Zhidong, et al.
Publicado: (2023)

In silico screening-based discovery of novel covalent inhibitors of the SARS-CoV-2 3CL protease
por: Xiong, Muya, et al.
Publicado: (2022)

Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease
por: Su, Haixia, et al.
Publicado: (2021)

Design, synthesis and biological evaluation of covalent peptidomimetic 3CL protease inhibitors containing nitrile moiety
por: Zhu, Mengwei, et al.
Publicado: (2023)

Design, synthesis and biological evaluation of peptidomimetic benzothiazolyl ketones as 3CL(pro) inhibitors against SARS-CoV-2
por: Yang, Hanxi, et al.
Publicado: (2023)

Ensemble Docking Coupled to Linear Interaction Energy Calculations for Identification of Coronavirus Main Protease (3CL(pro)) Non-Covalent Small-Molecule Inhibitors
por: Jukič, Marko, et al.
Publicado: (2020)

Discovery, synthesis and mechanism study of 2,3,5-substituted [1,2,4]-thiadiazoles as covalent inhibitors targeting 3C-Like protease of SARS-CoV-2
por: Ren, Pengxuan, et al.
Publicado: (2023)

Discovery and characterization of the covalent SARS-CoV-2 3CL(pro) inhibitors from Ginkgo biloba extract via integrating chemoproteomic and biochemical approaches
por: Zhang, Ya-Ni, et al.
Publicado: (2023)

Small Molecules, Non-Covalent Interactions, and Confinement
por: Buntkowsky, Gerd, et al.
Publicado: (2020)

Flavonoids in Ampelopsis grossedentata as covalent inhibitors of SARS-CoV-2 3CL(pro): Inhibition potentials, covalent binding sites and inhibitory mechanisms
por: Xiong, Yuan, et al.
Publicado: (2021)

Identification of Vitamin K3 and its analogues as covalent inhibitors of SARS-CoV-2 3CL(pro)
por: Wang, Ruyu, et al.
Publicado: (2021)

Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CL(pro) covalent inhibitors
por: Stille, Julia K., et al.
Publicado: (2022)

Detection of weak non-covalent cation-π interactions in NGAL by single-molecule force spectroscopy
por: Nie, Jingyuan, et al.
Publicado: (2022)

Structure-based virtual screening against SARS-3CL(pro) to identify novel non-peptidic hits
por: Mukherjee, Prasenjit, et al.
Publicado: (2008)

An update on the discovery and development of reversible covalent inhibitors
por: Faridoon, et al.
Publicado: (2023)

Covalent and Non-covalent Functionalized Nanomaterials for Environmental Restoration
por: Zhang, Shizhong, et al.
Publicado: (2022)

Structure-Function Relationships of Covalent and Non-Covalent BTK Inhibitors
por: Zain, Rula, et al.
Publicado: (2021)

CovalentInDB: a comprehensive database facilitating the discovery of covalent inhibitors
por: Du, Hongyan, et al.
Publicado: (2020)

Discovery of Non-peptide Small Molecule Allosteric Modulators of the Src-family Kinase, Hck
por: Dorman, Heather R., et al.
Publicado: (2019)

Discovery of novel SARS-CoV-2 3CL protease covalent inhibitors using deep learning-based screen
por: Wang, Liying, et al.
Publicado: (2022)

“Identification of Nafamostat and VR23 as COVID-19 drug candidates by targeting 3CL(pro) and PL(pro)"
por: Bhowmik, Deep, et al.
Publicado: (2021)

Correction to: Covalent and Non-covalent Functionalized Nanomaterials for Environmental Restoration
por: Zhang, Shizhong, et al.
Publicado: (2022)

Discovery of quinazolin-4-one-based non-covalent inhibitors targeting the severe acute respiratory syndrome coronavirus 2 main protease (SARS-CoV-2 M(pro))
por: Zhang, Kuojun, et al.
Publicado: (2023)

Dynamic covalent self-assembly of mechanically interlocked molecules solely made from peptides
por: Schröder, Hendrik V., et al.
Publicado: (2021)

Design, Synthesis and Evaluation of Fused Bicyclo[2.2.2]octene as a Potential Core Scaffold for the Non-Covalent Inhibitors of SARS-CoV-2 3CL(pro) Main Protease
por: Herlah, Barbara, et al.
Publicado: (2022)

Chitosan Functionalization: Covalent and Non-Covalent Interactions and Their Characterization
por: Nicolle, Laura, et al.
Publicado: (2021)

Fragment-based covalent ligand discovery
por: Lu, Wenchao, et al.
Publicado: (2021)

Non-covalent SARS-CoV-2 M(pro) inhibitors developed from in silico screen hits
por: Rossetti, Giacomo G., et al.
Publicado: (2022)

Designed switch from covalent to non-covalent inhibitors of carboxylesterase Notum activity
por: Atkinson, Benjamin N., et al.
Publicado: (2023)

Discovery of 9,10-dihydrophenanthrene derivatives as SARS-CoV-2 3CL(pro) inhibitors for treating COVID-19
por: Zhang, Jian-Wei, et al.
Publicado: (2022)

Advances in covalent drug discovery
por: Boike, Lydia, et al.
Publicado: (2022)

Novel Non-Peptide Inhibitors against SmCL1 of Schistosoma mansoni: In Silico Elucidation, Implications and Evaluation via Knowledge Based Drug Discovery
por: Zafar, Atif, et al.
Publicado: (2015)

A non-covalent peptide-based carrier for in vivo delivery of DNA mimics
por: Morris, May C., et al.
Publicado: (2007)

Tuning the stability of organic radicals: from covalent approaches to non-covalent approaches
por: Tang, Bohan, et al.
Publicado: (2020)

Experimental and Computational Studies on Non-Covalent Imprinted Microspheres as Recognition System for Nicotinamide Molecules
por: Del Sole, Roberta, et al.
Publicado: (2009)

Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities
por: Ahmed-Belkacem, Abdelhakim, et al.
Publicado: (2016)

Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CL(pro)
por: Du, Ruikun, et al.
Publicado: (2021)

Structure-based discovery of the first non-covalent inhibitors of Leishmania major tryparedoxin peroxidase by high throughput docking
por: Brindisi, Margherita, et al.
Publicado: (2015)

Covalent and non-covalent chemistry of 2D black phosphorus
por: Mitrović, Aleksandra, et al.
Publicado: (2021)

DNA-encoded chemical libraries yield non-covalent and non-peptidic SARS-CoV-2 main protease inhibitors
por: Jimmidi, Ravikumar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6n33ec8aum0pj47f919hpu9utt